Neonatal jaundice: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
== Background == | == Background == | ||
*Must distinguish between unconjugated and conjugated hyperbili | *Must distinguish between unconjugated and conjugated hyperbili | ||
**Conjugated is always pathologic | **Conjugated is always pathologic | ||
== Work-Up == | == Work-Up == | ||
#Tbil/Dbil | #Tbil/Dbil | ||
#CBC (for hemolytic anemia) | #CBC (for hemolytic anemia) | ||
| Line 13: | Line 9: | ||
== DDx == | == DDx == | ||
Common | |||
#Physiologic | |||
#Breast Milk Jaundice | #Breast Milk Jaundice | ||
##Due to substances in milk that inhibit glucuronyl transferase | ##Due to substances in milk that inhibit glucuronyl transferase | ||
| Line 21: | Line 18: | ||
##Pt does not receive adequate oral intake | ##Pt does not receive adequate oral intake | ||
###Results in reduced bowel movement/bilirubin excretion | ###Results in reduced bowel movement/bilirubin excretion | ||
Uncommon | |||
#Direct (conjugated, post- liver obstructive) | #Direct (conjugated, post- liver obstructive) | ||
##congenital biliary atresia | ##congenital biliary atresia | ||
| Line 54: | Line 35: | ||
##rH/ ABO incompatibility | ##rH/ ABO incompatibility | ||
== Treatment == | |||
*Breast Milk Jaundice | |||
**Do not need to routinely d/c breast-feeding | |||
**Treat w/ phototherapy when necessary | |||
*Breast-Feeding Jaundice | |||
**Supplement with expressed breast milk or formula | |||
*Exchange transfusion | |||
**Consider if signs of bilirubin encephalopathy | |||
***Hypertonia, arching, retrocollis, opisthotonos | |||
== Phototherapy Guidelines == | == Phototherapy Guidelines == | ||
| Line 107: | Line 96: | ||
== Risk Factors == | == Risk Factors == | ||
#Isoimmune hemolytic disease | #Isoimmune hemolytic disease | ||
#G6PD deficiency | #G6PD deficiency | ||
| Line 119: | Line 107: | ||
== Source == | == Source == | ||
UpToDate, Tintinalli | |||
[[Category:Peds]] | |||
Revision as of 22:49, 13 June 2011
Background
- Must distinguish between unconjugated and conjugated hyperbili
- Conjugated is always pathologic
Work-Up
- Tbil/Dbil
- CBC (for hemolytic anemia)
- Coombs or T&S (mom & baby)
DDx
Common
- Physiologic
- Breast Milk Jaundice
- Due to substances in milk that inhibit glucuronyl transferase
- May start as early as 3rd day, reaches peak by 3rd week of life
- Unlikely to cause kernicterus
- Breast-Feeding Jaundice (starvation jaundice)
- Pt does not receive adequate oral intake
- Results in reduced bowel movement/bilirubin excretion
- Pt does not receive adequate oral intake
Uncommon
- Direct (conjugated, post- liver obstructive)
- congenital biliary atresia
- neuroblastoma
- cholesterol cysts
- Cellular
- hepatitis
- galactosemia
- sepsis
- TORCHS
- tyrosinemia
- alpha 1 antitrypsis deficiency
- Indirect (unconjugated, pre-liver)
- sepsis
- hypotension
- rH/ ABO incompatibility
Treatment
- Breast Milk Jaundice
- Do not need to routinely d/c breast-feeding
- Treat w/ phototherapy when necessary
- Breast-Feeding Jaundice
- Supplement with expressed breast milk or formula
- Exchange transfusion
- Consider if signs of bilirubin encephalopathy
- Hypertonia, arching, retrocollis, opisthotonos
- Consider if signs of bilirubin encephalopathy
Phototherapy Guidelines
| Age | Low | Med | High |
| Birth | 7.0 | 5.0 | 4.0 |
| 24h | 11.5 | 9.0 | 8.0 |
| 48h | 15 | 14 | 10 |
| 72h | 17.5 | 15 | 14 |
| 96h | 20 | 17.5 |
14.5 |
| 5+day | 21 | 17.5 | 15 |
- Use total bilirubin
Low Risk: >=38wk + no risk factors
Med Risk: (>=38wk + risk factors) or (35-37 wk and no risk factors)
High Risk: 35-37wk + risk factors
Risk Factors
- Isoimmune hemolytic disease
- G6PD deficiency
- Asphyxia
- Significant lethargy
- Temperature instability
- Sepsis
- Acidosis
Source
UpToDate, Tintinalli
